Parkinson's Disease Pathophysiology: Dopamine Pathways Explained

Added:

Neuron Loss & Lewy Bodies
The 80% Threshold
Mechanism of Hypokinesia

Neuron Loss & Lewy Bodies

0:00
Playing Section
  • 1

    Dopamine neurons in the substantia nigra die in Parkinson's disease.

  • 2

    These neurons project to the striatum via the nigrostriatal pathway.

  • 3

    Lewy bodies form in neurons, but their exact role remains unknown.

Basic neuroanatomy of the brain, particularly the structure and general functions of the basal ganglia.
The fundamentals of neurotransmission, specifically how dopamine acts as a chemical messenger in the central nervous system.
The concept of excitatory and inhibitory neural pathways, including the roles of glutamate and GABA.
Basic physiology of voluntary motor control and how the cerebral cortex coordinates movement.
Pharmacological interventions for Parkinson's disease, including the mechanisms of L-DOPA, carbidopa, and dopamine agonists.
Advanced surgical treatments such as Deep Brain Stimulation (DBS) and how it modulates disrupted basal ganglia circuitry.
The cellular and molecular pathology of Parkinson's disease, focusing on alpha-synuclein aggregation and Lewy bodies.
Differential diagnosis of atypical Parkinsonian syndromes (Parkinson-plus syndromes) versus idiopathic Parkinson's disease.
155.1K views955likes5:59@emmagiles1411Original Release: 2015-02-24

Parkinson's disease causes movement problems like bradykinesia and rigidity when approximately 80% of dopamine neurons in the substantia nigra die, disrupting the nigrostriatal pathway that projects to the striatum; this loss impairs both the direct pathway (which normally loosens the thalamic 'leash' to enable movement) and the indirect pathway (which normally tightens the leash to reduce movement), resulting in reduced motor control.